Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

1.55
-0.0523-3.26%
Volume:68.24K
Turnover:107.24K
Market Cap:87.87M
PE:-0.69
High:1.61
Open:1.60
Low:1.50
Close:1.61
Loading ...

TScan Therapeutics Q4 Operating Expenses USD 37.377 Million

THOMSON REUTERS
·
05 Mar

TScan Therapeutics Q4 Net Income USD -35.809 Million

THOMSON REUTERS
·
05 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
05 Mar

TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
27 Feb

TScan Therapeutics Insider Ups Holding By 18% During Year

Simply Wall St.
·
05 Feb

Barclays Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
16 Jan

Here's Why TScan Therapeutics (TCRX) is Poised for a Turnaround After Losing -5.63% in 4 Weeks

Zacks
·
10 Jan

Sector Update: Health Care Stocks Edge Up in Afternoon Trading

MT Newswires Live
·
27 Dec 2024

TScan Shares Jump 23% on Securities Purchase Agreement

Dow Jones
·
26 Dec 2024

Sector Update: Health Care Stocks Steady Premarket Thursday

MT Newswires Live
·
26 Dec 2024

TScan Therapeutics Signs $30 Million Direct Offering; Shares Rise Pre-Bell

MT Newswires Live
·
26 Dec 2024

TScan Therapeutics announces $30M registered direct offering

TIPRANKS
·
26 Dec 2024

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

THOMSON REUTERS
·
26 Dec 2024

Press Release: TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

Dow Jones
·
26 Dec 2024

With 52% ownership, TScan Therapeutics, Inc. (NASDAQ:TCRX) boasts of strong institutional backing

Simply Wall St.
·
25 Dec 2024

TScan Therapeutics Secures $52.5M Loan from SVB

TIPRANKS
·
23 Dec 2024

TScan Therapeutics refinances existing convertible debt facility

TIPRANKS
·
23 Dec 2024

TScan Therapeutics Inc - Enters $52.5 Million Term Loan Facility With Svb

THOMSON REUTERS
·
23 Dec 2024

TScan Therapeutics Inc - Term Loans Mature on September 1, 2029

THOMSON REUTERS
·
23 Dec 2024

TScan Therapeutics Inc - Refinancing Expected to Fund Operating Plan Into Q4 2026

THOMSON REUTERS
·
23 Dec 2024